FDA stresses birth defect risks with Roche drug
Friday, May 16, 2008 - 17:35
in Health & Medicine
(AP) -- Health regulators warned again Friday that Roche and Novartis drugs prescribed to organ transplant patients can cause miscarriages and birth defects when used by pregnant women.
Read the whole article on Physorg
More from Physorg
Related
- Model predicts a drug's likelihood of causing birth defectsTue, 4 Jan 2011, 15:05:25 EST
- Prenatal use of newer antiepileptic drugs not associated with increased risk of major birth defectsTue, 17 May 2011, 19:35:06 EDT
- First-ever review finds smoking causes serious birth defectsTue, 12 Jul 2011, 10:34:29 EDT
- Increased risk of birth defects after PCE exposureWed, 23 Sep 2009, 19:43:10 EDT
- WSU researchers confirm key feature of age-related miscarriages and birth defectsThu, 14 Apr 2011, 13:54:34 EDT